跳至主要内容
临床试验/IRCT20120520009801N5
IRCT20120520009801N5招募中3 期

Evaluation the effect of Trans Sodium Crocetinate(TSC) on re perfusion Injury in Acute Myocardial Infarction with ST elevation segment: a triple-blind, randomized, placebo-controlled trial

Mashhad University of Medical Sciences0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 76 years(—)
性别
All

入选标准

  • Patients should be between 18 and 76 years old
  • Patients with myocardial infarction with an ascending ST segment
  • Meet the entry requirements under the AHA2019 guideline
  • Candidates for PPCI
  • Zero TIMI score at admission

排除标准

  • Be pregnant or breastfeeding
  • History of allergy to formulations used in the study.•
  • The patient enters another similar plan and receives other drugs that affect treatment response in the past month
  • The person has cardiogenic shock and is forced to use pressure therapy
  • The patient has IABP
  • History of acute myocardial infarction
  • GFR less than 60 ml / min•
  • Patients with cardiac arrest
  • Patient with VF
  • Patient with hepatic impairment AST / ALT> 5ULN
  • Patient with a history of chronic inflammatory disease
  • Patient with LMCA involvement
  • Patient with a history of myocardial infarction or ACS within 4 hours before the current episode

研究者

相似试验